Analyze Diet
Journal of veterinary internal medicine2024; 38(5); 2718-2728; doi: 10.1111/jvim.17185

Effects of fecal microbiota transplantation on clinical outcomes and fecal microbiota of foals with diarrhea.

Abstract: Diarrhea in foals can be associated with disruption of the intestinal microbiota (dysbiosis). Effective management of intestinal dysbiosis in foals has not been demonstrated. Objective: Fecal microbiota transplantation (FMT) in foals with diarrhea influences the intestinal microbiota and improves clinical and clinicopathological outcomes. Methods: Twenty-five foals <6 months of age with diarrhea and systemic inflammatory response syndrome at 3 veterinary hospitals. Methods: A prospective randomized placebo-controlled cohort study. Foals in the FMT group (n = 19) or control group (n = 9) received FMT or electrolyte solution once daily for 3 days. Fecal samples were obtained on Day 0 (D0), D1, D2, D3, and D7. Within group and between group data analyses were performed for clinical, clinicopathological, and microbiota variables. Results: Treatment had no effect on survival (FMT 79%; control 100%, P = .3) or resolution of diarrhea (FMT 68%; control 55%, P = .4). On D3, the white blood cell count of the FMT group was lower than the control group (D3 FMT group median 6.4 g/L [5-8.3 g/L]; D3 control group median 14.3 g/L [6.7-18.9 g/L] P = .04). Heart rate reduced over time in the FMT group (D0 median 80 bpm [60-150 bpm]; D2 median 70 bpm [52-110 bpm] [P = .005]; and D3 median 64, [54-102 bpm] [P < .001]). Phylum Verrucomicrobiota, genus Akkermansia, and family Prevotellaceae were enriched in the FMT group on D1 (linear discriminate analysis > 4). Conclusions: In foals with diarrhea, FMT appears safe and can be associated with some clinical and microbiota changes suggestive of beneficial effect.
Publication Date: 2024-09-12 PubMed ID: 39266472PubMed Central: PMC11423448DOI: 10.1111/jvim.17185Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated the effects of fecal microbiota transplantation (FMT) on foals under 6 months old suffering from diarrhea, focusing on clinical outcomes and changes in their intestinal microbiota.
  • The study aimed to evaluate whether FMT could improve health indicators and restore healthy gut bacteria compared to a control treatment with electrolyte solution.

Background and Purpose

  • Diarrhea in foals can lead to disruption of their intestinal microbiota, a condition called dysbiosis, which negatively impacts gut health and overall recovery.
  • Currently, effective treatments targeting microbiota restoration in foals with diarrhea are not well established.
  • The study’s objective was to determine if FMT could beneficially influence gut microbiota and clinical outcomes in diarrheic foals.

Study Design and Methods

  • Researchers conducted a prospective, randomized, placebo-controlled cohort study across three veterinary hospitals.
  • Participants consisted of 25 foals under 6 months old presenting with diarrhea and systemic inflammatory response syndrome (SIRS).
  • Foals were assigned to two groups:
    • FMT group (n=19): received fecal microbiota transplantation once daily for three days.
    • Control group (n=9): received an electrolyte solution placebo once daily for three days.
  • Fecal samples were collected from all foals on Day 0 (baseline), and Days 1, 2, 3, and 7 to analyze gut microbiota changes over time.
  • Clinical variables (e.g., white blood cell count, heart rate), clinicopathological data, and microbiota profiles were compared within groups over time and between groups.

Key Findings

  • Survival rates were not significantly different between groups: 79% in FMT group vs. 100% in controls (P=0.3).
  • Resolution of diarrhea showed no statistically significant difference: 68% in FMT group vs. 55% in controls (P=0.4).
  • By Day 3, foals in the FMT group had a significantly lower median white blood cell count compared to controls, indicating possible reduced inflammation or improved immune response:
    • FMT group median: 6.4 g/L (range 5-8.3 g/L)
    • Control group median: 14.3 g/L (range 6.7-18.9 g/L)
    • P=0.04 (significant)
  • Heart rates declined significantly over time in the FMT group, suggesting clinical improvement:
    • Day 0 median: 80 bpm (range 60-150 bpm)
    • Day 2 median: 70 bpm (range 52-110 bpm), P=0.005
    • Day 3 median: 64 bpm (range 54-102 bpm), P<0.001
  • Microbiota analysis showed enrichment of particular beneficial bacterial groups in the FMT group on Day 1:
    • Phylum Verrucomicrobiota
    • Genus Akkermansia
    • Family Prevotellaceae
    • This suggests that FMT can alter the intestinal bacterial composition toward potentially healthier profiles.

Conclusions and Implications

  • FMT was safe when used in foals with diarrhea, with no adverse survival outcomes noted.
  • While FMT did not significantly change survival rates or diarrhea resolution compared to controls, it was associated with some clinical improvements (e.g., reduced white blood cell count and heart rate) that may indicate a beneficial effect on inflammation and overall health.
  • Importantly, FMT appeared to shift the gut microbiota toward a composition featuring key beneficial bacteria, which could promote gut health and recovery.
  • These findings suggest that fecal microbiota transplantation warrants further investigation as a potential treatment for managing dysbiosis and improving clinical outcomes in foals with diarrhea.

Cite This Article

APA
Bell J, Radial SL, Cuming RS, Trope G, Hughes KJ. (2024). Effects of fecal microbiota transplantation on clinical outcomes and fecal microbiota of foals with diarrhea. J Vet Intern Med, 38(5), 2718-2728. https://doi.org/10.1111/jvim.17185

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 38
Issue: 5
Pages: 2718-2728

Researcher Affiliations

Bell, Jillian
  • Charles Sturt University School of Agricultural, Environmental and Veterinary Sciences, Wagga Wagga, New South Wales, Australia.
Radial, Sharanne L
  • Charles Sturt University School of Agricultural, Environmental and Veterinary Sciences, Wagga Wagga, New South Wales, Australia.
Cuming, Rosemary S
  • Scone Equine Hospital, Scone, New South Wales, Australia.
Trope, Gareth
  • South Eastern Equine Hospital, Narre Warren North, Victoria, Australia.
Hughes, Kristopher J
  • Charles Sturt University School of Agricultural, Environmental and Veterinary Sciences, Wagga Wagga, New South Wales, Australia.

MeSH Terms

  • Animals
  • Horses
  • Diarrhea / veterinary
  • Diarrhea / therapy
  • Diarrhea / microbiology
  • Fecal Microbiota Transplantation / veterinary
  • Horse Diseases / therapy
  • Horse Diseases / microbiology
  • Female
  • Feces / microbiology
  • Male
  • Gastrointestinal Microbiome
  • Prospective Studies
  • Treatment Outcome
  • Animals, Newborn
  • Dysbiosis / veterinary
  • Dysbiosis / therapy
  • Cohort Studies

Grant Funding

  • Agrifutures Australia

Conflict of Interest Statement

Kristopher J. Hughes serves as Associate Editor for the Journal of Veterinary Internal Medicine. He was not involved in review of this manuscript. No other authors declare a conflict of interest.

References

This article includes 49 references
  1. Urquhart K. Diarrhoea in foals. In Pract 1981;3:22‐29.
    pubmed: 6286504
  2. Frederick J, Giguère S, Sanchez LC. Infectious agents detected in the feces of diarrheic foals: a retrospective study of 233 cases (2003–2008). J Vet Intern Med 2009;23:1254‐1260.
    pmc: PMC7166729pubmed: 19747192
  3. Wong DM, Alcott CJ, Sponseller BA, Young JL, Sponseller BT. Impaired intestinal absorption of glucose in 4 foals with Lawsonia intracellularis infection. J Vet Intern Med 2009;23:940‐944.
    pubmed: 19566855
  4. Slovis NM, Elam J, Estrada M, Leutenegger CM. Infectious agents associated with diarrhoea in neonatal foals in central K entucky: a comprehensive molecular study. Equine Vet J 2014;46:311‐316.
    pmc: PMC7163618pubmed: 23773143
  5. Costa MC, Arroyo LG, Allen‐Vercoe E. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3‐V5 region of the 16S rRNA gene (equine fecal microbiota). Vet J 2012;7:e41484.
    pmc: PMC3409227pubmed: 22859989
  6. McKinney CA, Oliveira BCM, Bedenice D. The fecal microbiota of healthy donor horses and geriatric recipients undergoing fecal microbial transplantation for the treatment of diarrhea. PLoS One 2020;15:e0230148.
    pmc: PMC7064224pubmed: 32155205
  7. McKinney CA, Bedenice D, Pacheco AP. Assessment of clinical and microbiota responses to fecal microbial transplantation in adult horses with diarrhea. PLoS One 2021;16:e0244381.
    pmc: PMC7808643pubmed: 33444319
  8. Li Y, Lan Y, Zhang S, Wang X. Comparative analysis of gut microbiota between healthy and diarrheic horses. Front Vet Sci 2022;9:882423.
    pmc: PMC9108932pubmed: 35585860
  9. Arnold CE, Pilla R, Chaffin MK. The effects of signalment, diet, geographic location, season, and colitis associated with antimicrobial use or salmonella infection on the fecal microbiome of horses. J Vet Intern Med 2021;35:2437‐2448.
    pmc: PMC8478058pubmed: 34268795
  10. Schoster A, Staempfli HR, Guardabassi LG, Jalali M, Weese JS. Comparison of the fecal bacterial microbiota of healthy and diarrheic foals at two and four weeks of life. BMC Vet Res 2017;13:144.
    pmc: PMC5450145pubmed: 28558788
  11. De La Torre U, Henderson JD, Furtado KL. Utilizing the fecal microbiota to understand foal gut transitions from birth to weaning. PLoS One 2019;14:e0216211.
    pmc: PMC6490953pubmed: 31039168
  12. Oliver‐Espinosa O. Foal diarrhea: established and postulated causes, prevention, diagnostics, and treatments. Vet Clinic North Am Equine Pract 2018;34:55‐68.
    pmc: PMC7134762pubmed: 29395727
  13. Liepman RS, Swink JM, Habing GG. Effects of intravenous antimicrobial drugs on the equine fecal microbiome. Animals 2022;12:1013.
    pmc: PMC9030835pubmed: 35454258
  14. Arnold CE, Isaiah A, Pilla R. The cecal and fecal microbiomes and metabolomes of horses before and after metronidazole administration. PLoS One 2020;15:e0232905.
    pmc: PMC7244109pubmed: 32442163
  15. Costa MC, Stampfli H, Arroyo L. Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs. BMC Vet Res 2015;11:19.
    pmc: PMC4323147pubmed: 25644524
  16. Weese JS, Anderson MEC, Lowe A. Preliminary investigation of the probiotic potential of lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety. Can Vet J 2003;44:299‐302.
    pmc: PMC372248pubmed: 12715981
  17. Weese JS, Anderson MEC, Lowe A. Screening of the equine intestinal microflora for potential probiotic organisms. Equine Vet J 2004;36:351‐355.
    pubmed: 15163044
  18. Schoster A, Staempfli HR, Abrahams M, Jalali M, Weese JS, Guardabassi L. Effect of a probiotic on prevention of diarrhea and Clostridium difficile and Clostridium perfringens shedding in foals. J Vet Intern Med 2015;29:925‐931.
    pmc: PMC4895414pubmed: 25903509
  19. Weese JS, Rousseau J. Evaluation of lactobacillus pentosus WE7 for prevention of diarrhea in neonatal foals. J Am Vet Med Assoc 2005;226:2031‐2034.
    pubmed: 15989186
  20. Ströbel C, Günther E, Romanowski K, Büsing K, Urubschurov V, Zeyner A. Effects of oral supplementation of probiotic strains of Lactobacillus rhamnosus and Enterococcus faecium on diarrhoea events of foals in their first weeks of life. J Anim Phys Anim Nutr (Berl) 2018;102:1357‐1365.
    pubmed: 29790614
  21. Quattrini C, Bozorgmanesh R, Egli P, Magdesian K. Fecal microbiota transplant for treatment of diarrhea in adult hospitalized horses—111 cases (2013–2018). Open Vet J 2023;13:1135‐1140.
    pmc: PMC10576572pubmed: 37842104
  22. Costa M, Di Pietro R, Bessegatto JA. Evaluation of changes in microbiota after fecal microbiota transplantation in 6 diarrheic horses. Can Vet J 2021;62:1123‐1130.
    pmc: PMC8439339pubmed: 34602643
  23. Kinoshita Y, Niwa H, Uchida‐Fujii E, Nukada T, Ueno T. Simultaneous daily fecal microbiota transplantation fails to prevent metronidazole‐induced dysbiosis of equine gut microbiota. J Equ Vet Sci 2022;114:104004.
    pubmed: 35526726
  24. Laustsen L, Edwards JE, Hermes GDA. Free faecal water: analysis of horse faecal microbiota and the impact of faecal microbial transplantation on symptom severity. Animals 2021;11:2776.
    pmc: PMC8533009pubmed: 34679798
  25. Callahan BJ, McMurdie PJ, Rosen MJ. DADA2: high‐resolution sample inference from Illumina amplicon data. Nat Methods 2016;13:581‐583.
    pmc: PMC4927377pubmed: 27214047
  26. Bokulich NA, Kaehler BD, Rideout JR. Optimizing taxonomic classification of marker‐gene amplicon sequences with QIIME 2's q2‐feature‐classifier plugin. Microbiome 2018;6:90.
    pmc: PMC5956843pubmed: 29773078
  27. Bolyen E, Rideout JR, Dillon MR. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019;37:852‐857.
    pmc: PMC7015180pubmed: 31341288
  28. Li B, Zhang X, Guo F, Wu W, Zhang T. Characterization of tetracycline resistant bacterial community in saline activated sludge using batch stress incubation with high‐throughput sequencing analysis. Water Res 2013;47:4207‐4216.
    pubmed: 23764571
  29. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005;71:8228‐8235.
    pmc: PMC1317376pubmed: 16332807
  30. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. ISME J 2011;5:169‐172.
    pmc: PMC3105689pubmed: 20827291
  31. Lozupone CA, Hamady M, Kelley ST, Knight R. Quantitative and qualitative β diversity measures lead to different insights into factors that structure microbial communities.. Appl Environ Microbiol 2007;73:1576‐1585.
    pmc: PMC1828774pubmed: 17220268
  32. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples).. Biometrika 1965;52:591‐611.
  33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing.. J R Stat Soc B Methodol 1995;57:289‐300.
  34. Segata N, Izard J, Waldron L. Metagenomic biomarker discovery and explanation.. Genome Biol 2011;12:R60.
    pmc: PMC3218848pubmed: 21702898
  35. Kruskal WH, Wallis WA. Errata: use of ranks in one‐criterion variance analysis.. J Am Stat Assoc 1953;48:907‐911.
  36. Maslen BN, Duff C, Clark SA, van der Werf J, White JD, Pant SD. Increased yearling weight gain is associated with a distinct faecal microbial profile.. Animals 2023;13:3062.
    pmc: PMC10572062pubmed: 37835668
  37. Costa MC, Weese JS. Understanding the intestinal microbiome in health and disease.. V Clin North Am Equine Pract 2018;34:1‐12.
    pubmed: 29402480
  38. Stewart HL, Pitta D, Indugu N, Vecchiarelli B, Engiles JB, Southwood LL. Characterization of the fecal microbiota of healthy horses.. Am J Vet Res 2018;79:811‐819.
    pubmed: 30058849
  39. Dias DPM, Sousa SS, Molezini FA, Ferreira HSD, Campos R. Efficacy of faecal microbiota transplantation for treating acute colitis in horses undergoing colic surgery.. Pesqui Vet Bras 2018;38:1564‐1569.
  40. Salem SE, Maddox TW, Berg A. Variation in faecal microbiota in a group of horses managed at pasture over a 12‐month period.. Sci Rep 2018;8:8510.
    pmc: PMC5981443pubmed: 29855517
  41. Costa MC, Stämpfli HR, Allen‐Vercoe E, Weese JS. Development of the faecal microbiota in foals.. Equine Vet J 2016;48:681‐688.
    pubmed: 26518456
  42. Everard A, Belzer C, Geurts L. Cross‐talk between Akkermansia muciniphila and intestinal epithelium controls diet‐induced obesity.. Proc Nat Acad Sci– U S A 2013;110:9066‐9071.
    pmc: PMC3670398pubmed: 23671105
  43. Bedarf JR, Hildebrand F, Coelho LP. Functional implications of microbial and viral gut metagenome changes in early stage L‐DOPA‐naïve Parkinson's disease patients.. Genome Med 2017;9:39.
    pmc: PMC5408370pubmed: 28449715
  44. Liu Y, Bailey KE, Dyall‐Smith M. Faecal microbiota and antimicrobial resistance gene profiles of healthy foals.. Equine Vet J 2021;53:806‐816.
    pubmed: 33030244
  45. Stewart HL, Pitta D, Indugu N. Changes in the faecal bacterial microbiota during hospitalisation of horses with colic and the effect of different causes of colic.. Equine Vet J 2021;53:1119‐1131.
    pubmed: 33222287
  46. Theelen MJP, Luiken REC, Wagenaar JA. Longitudinal study of the short‐ and long‐term effects of hospitalisation and oral trimethoprim‐sulfadiazine administration on the equine faecal microbiome and resistome.. Microbiome 2023;11:33.
    pmc: PMC9969626pubmed: 36850017
  47. Barr BS, Waldridge BM, Morresey PR. Antimicrobial‐associated diarrhoea in three equine referral practices.. Equine Vet J 2013;45:154‐158.
    pubmed: 22779907
  48. Chapuis RJJ, Becker AAMJ, Dowling PM, Weese JS. Characterisation of faecal microbiota in horses medicated with oral doxycycline hyclate.. Equine Vet J 2022;55:129‐141.
    pubmed: 35202500
  49. Gomez D, Toribio R, Caddey B, Costa M, Vijan S, Dembek K. Longitudinal effects of oral administration of antimicrobial drugs on fecal microbiota of horses.. J Vet Intern Med 2023;37:2562‐2572.
    pmc: PMC10658497pubmed: 37681574

Citations

This article has been cited 2 times.
  1. Tian R, Chong CJ, Bai YY, Chen N, Qiao RR, Wang K, Wang YW, Zhao P, Zhao CB, Tang YP, Zhang L, Zhang Q. The role of gut microbiota in diarrhea and its alleviation through microbiota-targeted interventions. Front Microbiol 2025;16:1630823.
    doi: 10.3389/fmicb.2025.1630823pubmed: 41229686google scholar: lookup
  2. Cantas L, Goll R, Fenton CG, Paulssen RH, Sørum H. Impact of fecal microbiota transplantation in dogs. Front Vet Sci 2025;12:1505226.
    doi: 10.3389/fvets.2025.1505226pubmed: 40666732google scholar: lookup